NuGenerex Immuno-Oncology
https://www.generex.com/nugenerex-family-of-companies
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From NuGenerex Immuno-Oncology
Asia Deal Watch: China Grand, ETheRNA Create mRNA Vaccine JV
Plus deals involving LegoChem/Pyxix, Biohaven/Sosei Heptares, Kyowa Kirin/Helsinn, Dr. Reddy’s/Glenmark, Eisai/Wren, KoBioLabs/Kolmar Korea, Y-Biologics/Pierre Fabre, Generex/Chinese consortium.
Coronavirus Update: Inside Moderna's Deal With The US
Company receives a base payment of $1.225bn for the manufacturing and delivery of the first 100 million disease, plus a bonus if mRNA-1273 reaches the market quickly.
Company Information
- Industry
- Medical Devices
-
Pharmaceuticals
- Drug Delivery
- Vaccines
-
Biotechnology
- Large Molecule
- Other Names / Subsidiaries
-
- NuGenerex Immuno-Oncology, NuGenerex Diagnostics, NuGenerex Therapeutics
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
NuGenerex Immuno-Oncology
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice